Amélie Dendooven

1.6k total citations
61 papers, 873 citations indexed

About

Amélie Dendooven is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amélie Dendooven has authored 61 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Nephrology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amélie Dendooven's work include Renal Diseases and Glomerulopathies (8 papers), Connective Tissue Growth Factor Research (8 papers) and Chronic Kidney Disease and Diabetes (6 papers). Amélie Dendooven is often cited by papers focused on Renal Diseases and Glomerulopathies (8 papers), Connective Tissue Growth Factor Research (8 papers) and Chronic Kidney Disease and Diabetes (6 papers). Amélie Dendooven collaborates with scholars based in Belgium, Netherlands and United States. Amélie Dendooven's co-authors include Tri Q. Nguyen, Roel Goldschmeding, Robbert J. Kok, Jan Willem Leeuwis, Jaap A. Joles, Dionne M. van der Giezen, David Ishola, Karin G. F. Gerritsen, Alferso C Abrahams and Steven Van Laecke and has published in prestigious journals such as PLoS ONE, Advanced Drug Delivery Reviews and Scientific Reports.

In The Last Decade

Amélie Dendooven

53 papers receiving 861 citations

Peers

Amélie Dendooven
Maddalena Gigante Italy
Silvano Palazzo Italy
Marius C. van den Heuvel Netherlands
Antonia Loverre Italy
Julia Menke United States
Mercedes Gómez‐Morales Spain
Anna M. Leliveld Netherlands
Mazen Arar United States
Søren Krag Denmark
Joseph Weisstuch United States
Maddalena Gigante Italy
Amélie Dendooven
Citations per year, relative to Amélie Dendooven Amélie Dendooven (= 1×) peers Maddalena Gigante

Countries citing papers authored by Amélie Dendooven

Since Specialization
Citations

This map shows the geographic impact of Amélie Dendooven's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amélie Dendooven with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amélie Dendooven more than expected).

Fields of papers citing papers by Amélie Dendooven

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amélie Dendooven. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amélie Dendooven. The network helps show where Amélie Dendooven may publish in the future.

Co-authorship network of co-authors of Amélie Dendooven

This figure shows the co-authorship network connecting the top 25 collaborators of Amélie Dendooven. A scholar is included among the top collaborators of Amélie Dendooven based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amélie Dendooven. Amélie Dendooven is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Deman, Frederik, Glenn Broeckx, Inti Zlobec, et al.. (2025). Practical consequences of the European union-AI act for anatomic pathology laboratories a European society of pathology and European society of digital and integrative pathology commissioned expert opinion paper. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin.
2.
Deman, Frederik, et al.. (2025). Practical implementation of AI in a non‐academic, non‐commercial Pathology laboratory: Real world experience and lessons learned. Histopathology. 87(5). 635–646. 1 indexed citations
3.
Coemans, Maarten, Amélie Dendooven, Priyanka Koshy, et al.. (2025). Primary FSGS is not associated with worse kidney outcome compared with other FSGS subtypes. Clinical Kidney Journal. 18(4). sfaf060–sfaf060.
4.
Schutter, Harlinde De, et al.. (2025). Obstacles and drivers in the adoption of Standardized Structured Reporting (SSR): insights from pathologists. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 487(1). 163–173.
5.
Gevaert, Andreas B., et al.. (2024). Divergent cardiac and renal effects of miR-181c-5p inhibition in a rodent heart failure model. Frontiers in Cardiovascular Medicine. 11. 1383046–1383046. 1 indexed citations
6.
Sprangers, Ben, Alferso C Abrahams, Priyanka Koshy, et al.. (2024). Proliferative glomerulonephritis with monoclonal immunoglobulin deposits in the native or posttransplant kidney. Nephrology Dialysis Transplantation. 39(5). 888–892. 2 indexed citations
7.
Delrue, Charlotte, et al.. (2024). Advancing Renal Amyloidosis Care: The Role of Modern Diagnostic Techniques with the Potential of Enhancing Patient Outcomes. International Journal of Molecular Sciences. 25(11). 5875–5875. 2 indexed citations
8.
Roy, Nadine Van, Philip Vlummens, Amélie Dendooven, et al.. (2024). Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging. Insights into Imaging. 15(1). 106–106. 1 indexed citations
9.
Li, Kan Yan Chloe, Hector Dejea, Koen De Winne, et al.. (2023). Feasibility and safety of synchrotron-based X-ray phase contrast imaging as a technique complementary to histopathology analysis. Histochemistry and Cell Biology. 160(5). 377–389. 4 indexed citations
10.
Karam, Sabine, Iman Abou Dalle, Amélie Dendooven, et al.. (2023). Monoclonal gammopathy of renal significance: Multidisciplinary approach to diagnosis and treatment. Critical Reviews in Oncology/Hematology. 183. 103926–103926. 1 indexed citations
11.
Smet, Maarten De, et al.. (2022). Case report: Hemorrhagic fever with renal syndrome presenting as hemophagocytic lymphohistiocytosis. Frontiers in Medicine. 9. 1096900–1096900. 3 indexed citations
12.
Dendooven, Amélie, et al.. (2021). Canalicular stenosis associated with dupilumab treatment for atopic dermatitis. European Journal of Dermatology. 31(6). 843–844. 3 indexed citations
13.
Linden, Malaïka Van Der, Kristoff Muylle, Dries Deeren, et al.. (2020). Shallow-depth sequencing of cell-free DNA for Hodgkin and diffuse large B-cell lymphoma (differential) diagnosis: a standardized approach with underappreciated potential. Haematologica. 107(1). 211–220. 20 indexed citations
14.
Gielis, Els M., Charlie Beirnaert, Amélie Dendooven, et al.. (2018). Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay. PLoS ONE. 13(12). e0208207–e0208207. 58 indexed citations
15.
Dendooven, Amélie, et al.. (2017). Pulmonary artery aneurysms and thrombi. Thorax. 72(12). 1167–1168. 1 indexed citations
16.
Pehlivanoğlu, Burçin, et al.. (2017). How does it feel to be a pathology resident? Results of a survey on experiences and job satisfaction during pathology residency. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 471(3). 413–422. 9 indexed citations
17.
Rolfo, Christian, Pieter‐Jan van Dam, Amélie Dendooven, et al.. (2016). Multidisciplinary molecular tumour board : a tool to improve clinical practice and selection accrual for clinical trials in cancer patients. Ghent University Academic Bibliography (Ghent University). 1 indexed citations
18.
Gielis, Els M., Kristien J. Ledeganck, Hans Wils, et al.. (2016). SO002QUANTIFICATION OF PLASMA DONOR-DERIVED CELL-FREE DNA TO MONITOR KIDNEY TRANSPLANT HEALTH: PRELIMINARY RESULTS OF A SINGLE TUBE MULTIPLEX PCR ASSAY. Nephrology Dialysis Transplantation. 31(suppl_1). i1–i1. 4 indexed citations
19.
20.
Falke, Lucas L., Amélie Dendooven, Jan Willem Leeuwis, et al.. (2012). Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney. Matrix Biology. 31(7-8). 421–431. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maddalena Gigante Breakdown of academic impact, for papers by Silvano Palazzo Breakdown of academic impact, for papers by Marius C. van den Heuvel Breakdown of academic impact, for papers by Antonia Loverre Breakdown of academic impact, for papers by Julia Menke Breakdown of academic impact, for papers by Mercedes Gómez‐Morales Breakdown of academic impact, for papers by Anna M. Leliveld Breakdown of academic impact, for papers by Mazen Arar Breakdown of academic impact, for papers by Søren Krag Breakdown of academic impact, for papers by Joseph Weisstuch
Rankless by CCL
2026